ALK and neoplasm: Meanwhile, new advances have emerged regarding the immunotherapy of ALK fusion cancers, such as combination regimens of immunosuppressive agents, tumor vaccines, ALK chimeric antigen receptor (CAR-T) therapy, adoptive T cell therapy, and ALK antibodies.